Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 510

1.

Too many targets, not enough patients: rethinking neuroblastoma clinical trials.

Fletcher JI, Ziegler DS, Trahair TN, Marshall GM, Haber M, Norris MD.

Nat Rev Cancer. 2018 Apr 9. doi: 10.1038/s41568-018-0003-x. [Epub ahead of print] Review.

PMID:
29632319
2.

Network modeling of microRNA-mRNA interactions in neuroblastoma tumorigenesis identifies miR-204 as a direct inhibitor of MYCN.

Ooi CY, Carter DR, Liu B, Mayoh C, Beckers A, Lalwani A, Nagy Z, De Brouwer S, Decaesteker B, Hung TT, Norris MD, Haber M, Liu T, De Preter K, Speleman F, Cheung BB, Marshall GM.

Cancer Res. 2018 Apr 2. pii: canres.3034.2017. doi: 10.1158/0008-5472.CAN-17-3034. [Epub ahead of print]

PMID:
29610116
3.

Vascular Abnormalities within Normal Appearing Tissue in Chronic Traumatic Brain Injury.

Haber M, Amyot F, Kenney K, Meredith-Duliba T, Moore C, Silverman E, Podell J, Chou YY, Pham DL, Butman J, Lu H, Diaz-Arrastia R, Sandsmark D.

J Neurotrauma. 2018 Apr 2. doi: 10.1089/neu.2018.5684. [Epub ahead of print]

PMID:
29609518
4.

MAX to MYCN intracellular ratio drives the aggressive phenotype and clinical outcome of high risk neuroblastoma.

Ferrucci F, Ciaccio R, Monticelli S, Pigini P, di Giacomo S, Purgato S, Erriquez D, Bernardoni R, Norris M, Haber M, Milazzo G, Perini G.

Biochim Biophys Acta. 2018 Mar;1861(3):235-245. doi: 10.1016/j.bbagrm.2018.01.007. Epub 2018 Feb 3.

PMID:
29408445
5.

Response to Giem.

Haber M, Doumet-Serhal C, Scheib C, Xue Y, Danecek P, Mezzavilla M, Youhanna S, Martiniano R, Prado-Martinez J, Szpak M, Matisoo-Smith E, Schutkowski H, Mikulski R, Zalloua P, Kivisild T, Tyler-Smith C.

Am J Hum Genet. 2018 Feb 1;102(2):331. doi: 10.1016/j.ajhg.2018.01.002. No abstract available.

PMID:
29395077
6.

A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination.

Shi M, An Q, Ainslie KEC, Haber M, Orenstein WA.

BMC Infect Dis. 2017 Dec 8;17(1):757. doi: 10.1186/s12879-017-2838-2.

7.

A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.

Sutton R, Venn NC, Law T, Boer JM, Trahair TN, Ng A, Den Boer ML, Dissanayake A, Giles JE, Dalzell P, Mayoh C, Barbaric D, Revesz T, Alvaro F, Pieters R, Haber M, Norris MD, Schrappe M, Dalla Pozza L, Marshall GM.

Br J Haematol. 2018 Feb;180(4):550-562. doi: 10.1111/bjh.15056. Epub 2017 Nov 30.

PMID:
29194562
8.

Maximum likelihood estimation of influenza vaccine effectiveness against transmission from the household and from the community.

Ainslie KEC, Haber MJ, Malosh RE, Petrie JG, Monto AS.

Stat Med. 2018 Mar 15;37(6):970-982. doi: 10.1002/sim.7558. Epub 2017 Nov 28.

PMID:
29193179
9.

On the bias of estimates of influenza vaccine effectiveness from test-negative studies.

Ainslie KEC, Shi M, Haber M, Orenstein WA.

Vaccine. 2017 Dec 19;35(52):7297-7301. doi: 10.1016/j.vaccine.2017.10.107. Epub 2017 Nov 13.

PMID:
29146382
10.

Imaging of Cerebrovascular Function in Chronic Traumatic Brain Injury.

Amyot F, Kenney K, Moore C, Haber M, Turtzo LC, Shenouda C, Silverman E, Gong Y, Qu BX, Harburg L, Lu HY, Wassermann EM, Diaz-Arrastia R.

J Neurotrauma. 2018 Mar 20. doi: 10.1089/neu.2017.5114. [Epub ahead of print]

PMID:
29065769
11.

Author Correction: Surface properties of SAR11 bacteria facilitate grazing avoidance.

Dadon-Pilosof A, Conley KR, Jacobi Y, Haber M, Lombard F, Sutherland KR, Steindler L, Tikochinski Y, Richter M, Glöckner FO, Suzuki MT, West NJ, Genin A, Yahel G.

Nat Microbiol. 2017 Dec;2(12):1696. doi: 10.1038/s41564-017-0064-8.

PMID:
29057995
12.

Surface properties of SAR11 bacteria facilitate grazing avoidance.

Dadon-Pilosof A, Conley KR, Jacobi Y, Haber M, Lombard F, Sutherland KR, Steindler L, Tikochinski Y, Richter M, Glöckner FO, Suzuki MT, West NJ, Genin A, Yahel G.

Nat Microbiol. 2017 Dec;2(12):1608-1615. doi: 10.1038/s41564-017-0030-5. Epub 2017 Oct 2. Erratum in: Nat Microbiol. 2017 Dec;2(12 ):1696.

PMID:
28970475
13.

Defining an Analytic Framework to Evaluate Quantitative MRI Markers of Traumatic Axonal Injury: Preliminary Results in a Mouse Closed Head Injury Model.

Haber M, Hutchinson EB, Sadeghi N, Cheng WH, Namjoshi D, Cripton P, Irfanoglu MO, Wellington C, Diaz-Arrastia R, Pierpaoli C.

eNeuro. 2017 Sep 13;4(5). pii: ENEURO.0164-17.2017. doi: 10.1523/ENEURO.0164-17.2017. eCollection 2017 Sep-Oct.

14.

Continuity and Admixture in the Last Five Millennia of Levantine History from Ancient Canaanite and Present-Day Lebanese Genome Sequences.

Haber M, Doumet-Serhal C, Scheib C, Xue Y, Danecek P, Mezzavilla M, Youhanna S, Martiniano R, Prado-Martinez J, Szpak M, Matisoo-Smith E, Schutkowski H, Mikulski R, Zalloua P, Kivisild T, Tyler-Smith C.

Am J Hum Genet. 2017 Aug 3;101(2):274-282. doi: 10.1016/j.ajhg.2017.06.013. Epub 2017 Jul 27.

15.

Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo.

Murray J, Valli E, Yu DMT, Truong AM, Gifford AJ, Eden GL, Gamble LD, Hanssen KM, Flemming CL, Tan A, Tivnan A, Allan S, Saletta F, Cheung L, Ruhle M, Schuetz JD, Henderson MJ, Byrne JA, Norris MD, Haber M, Fletcher JI.

Eur J Cancer. 2017 Sep;83:132-141. doi: 10.1016/j.ejca.2017.06.024. Epub 2017 Jul 20.

PMID:
28735070
16.

Minocycline plus N-acteylcysteine induces remyelination, synergistically protects oligodendrocytes, and modifies neuroinflammation in a rat model of mild traumatic brain injury.

Haber M, James J, Kim J, Sangobowale M, Irizarry R, Ho J, Nikulina E, Grin'kina NM, Ramadani A, Hartman I, Bergold PJ.

J Cereb Blood Flow Metab. 2017 Jan 1:271678X17718106. doi: 10.1177/0271678X17718106. [Epub ahead of print]

PMID:
28685618
17.

Enrichment of low-frequency functional variants revealed by whole-genome sequencing of multiple isolated European populations.

Xue Y, Mezzavilla M, Haber M, McCarthy S, Chen Y, Narasimhan V, Gilly A, Ayub Q, Colonna V, Southam L, Finan C, Massaia A, Chheda H, Palta P, Ritchie G, Asimit J, Dedoussis G, Gasparini P, Palotie A, Ripatti S, Soranzo N, Toniolo D, Wilson JF, Durbin R, Tyler-Smith C, Zeggini E.

Nat Commun. 2017 Jun 23;8:15927. doi: 10.1038/ncomms15927.

18.

Extensive Proliferation of Human Cancer Cells with Ever-Shorter Telomeres.

Dagg RA, Pickett HA, Neumann AA, Napier CE, Henson JD, Teber ET, Arthur JW, Reynolds CP, Murray J, Haber M, Sobinoff AP, Lau LMS, Reddel RR.

Cell Rep. 2017 Jun 20;19(12):2544-2556. doi: 10.1016/j.celrep.2017.05.087.

19.

Estimating Direct and Indirect Protective Effect of Influenza Vaccination in the United States.

Arinaminpathy N, Kim IK, Gargiullo P, Haber M, Foppa IM, Gambhir M, Bresee J.

Am J Epidemiol. 2017 Jul 1;186(1):92-100. doi: 10.1093/aje/kwx037.

20.

Mapping Post-Glacial expansions: The Peopling of Southwest Asia.

Platt DE, Haber M, Dagher-Kharrat MB, Douaihy B, Khazen G, Ashrafian Bonab M, Salloum A, Mouzaya F, Luiselli D, Tyler-Smith C, Renfrew C, Matisoo-Smith E, Zalloua PA.

Sci Rep. 2017 Jan 6;7:40338. doi: 10.1038/srep40338.

21.

Development of a Pediatric Adverse Events Terminology.

Gipson DS, Kirkendall ES, Gumbs-Petty B, Quinn T, Steen A, Hicks A, McMahon A, Nicholas S, Zhao-Wong A, Taylor-Zapata P, Turner M, Herreshoff E, Jones C, Davis JM, Haber M, Hirschfeld S.

Pediatrics. 2017 Jan;139(1). pii: e20160985. doi: 10.1542/peds.2016-0985.

22.

Recommendations for the standardization of bone marrow disease assessment and reporting in children with neuroblastoma on behalf of the International Neuroblastoma Response Criteria Bone Marrow Working Group.

Burchill SA, Beiske K, Shimada H, Ambros PF, Seeger R, Tytgat GA, Brock PR, Haber M, Park JR, Berthold F.

Cancer. 2017 Apr 1;123(7):1095-1105. doi: 10.1002/cncr.30380. Epub 2016 Dec 16. Review.

23.

A Myc Activity Signature Predicts Poor Clinical Outcomes in Myc-Associated Cancers.

Jung M, Russell AJ, Liu B, George J, Liu PY, Liu T, DeFazio A, Bowtell DD, Oberthuer A, London WB, Fletcher JI, Haber M, Norris MD, Henderson MJ.

Cancer Res. 2017 Feb 15;77(4):971-981. doi: 10.1158/0008-5472.CAN-15-2906. Epub 2016 Dec 6.

24.

Chad Genetic Diversity Reveals an African History Marked by Multiple Holocene Eurasian Migrations.

Haber M, Mezzavilla M, Bergström A, Prado-Martinez J, Hallast P, Saif-Ali R, Al-Habori M, Dedoussis G, Zeggini E, Blue-Smith J, Wells RS, Xue Y, Zalloua PA, Tyler-Smith C.

Am J Hum Genet. 2016 Dec 1;99(6):1316-1324. doi: 10.1016/j.ajhg.2016.10.012. Epub 2016 Nov 23.

25.

Metagenomic analysis reveals unusually high incidence of proteorhodopsin genes in the ultraoligotrophic Eastern Mediterranean Sea.

Dubinsky V, Haber M, Burgsdorf I, Saurav K, Lehahn Y, Malik A, Sher D, Aharonovich D, Steindler L.

Environ Microbiol. 2017 Mar;19(3):1077-1090. doi: 10.1111/1462-2920.13624. Epub 2017 Mar 1.

PMID:
27871126
26.

The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs.

Liu PY, Sokolowski N, Guo ST, Siddiqi F, Atmadibrata B, Telfer TJ, Sun Y, Zhang L, Yu D, Mccarroll J, Liu B, Yang RH, Guo XY, Tee AE, Itoh K, Wang J, Kavallaris M, Haber M, Norris MD, Cheung BB, Byrne JA, Ziegler DS, Marshall GM, Dinger ME, Codd R, Zhang XD, Liu T.

Oncotarget. 2016 Nov 29;7(48):79217-79232. doi: 10.18632/oncotarget.12640.

27.

Righting Reflex Predicts Long-Term Histological and Behavioral Outcomes in a Closed Head Model of Traumatic Brain Injury.

Grin'kina NM, Li Y, Haber M, Sangobowale M, Nikulina E, Le'Pre C, El Sehamy AM, Dugue R, Ho JS, Bergold PJ.

PLoS One. 2016 Sep 22;11(9):e0161053. doi: 10.1371/journal.pone.0161053. eCollection 2016.

28.

USE DATA IN DIGITAL MARKETING.

Haber M, Sanghani R.

Behav Healthc. 2016 Spring;36(2):10-1. No abstract available.

PMID:
27505973
29.

MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.

Xue C, Yu DM, Gherardi S, Koach J, Milazzo G, Gamble L, Liu B, Valli E, Russell AJ, London WB, Liu T, Cheung BB, Marshall GM, Perini G, Haber M, Norris MD.

Oncotarget. 2016 Aug 23;7(34):54937-54951. doi: 10.18632/oncotarget.10709.

30.

Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth.

Vittorio O, Brandl M, Cirillo G, Kimpton K, Hinde E, Gaus K, Yee E, Kumar N, Duong H, Fleming C, Haber M, Norris M, Boyer C, Kavallaris M.

Oncotarget. 2016 Jul 26;7(30):47479-47493. doi: 10.18632/oncotarget.10201.

31.

CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements.

Somers K, Chudakova DA, Middlemiss SM, Wen VW, Clifton M, Kwek A, Liu B, Mayoh C, Bongers A, Karsa M, Pan S, Cruikshank S, Scandlyn M, Hoang W, Imamura T, Kees UR, Gudkov AV, Chernova OB, Haber M, Norris MD, Henderson MJ.

Oncotarget. 2016 Jul 19;7(29):46067-46087. doi: 10.18632/oncotarget.10022.

32.

Effects of Extracurricular Participation on the Internalizing Problems and Intrapersonal Strengths of Youth in a System of Care.

Abraczinskas M, Kilmer R, Haber M, Cook J, Zarrett N.

Am J Community Psychol. 2016 Jun;57(3-4):308-19. doi: 10.1002/ajcp.12048. Epub 2016 May 12.

PMID:
27216561
33.

MYC-Driven Neuroblastomas Are Addicted to a Telomerase-Independent Function of Dyskerin.

O'Brien R, Tran SL, Maritz MF, Liu B, Kong CF, Purgato S, Yang C, Murray J, Russell AJ, Flemming CL, von Jonquieres G, Pickett HA, London WB, Haber M, Gunaratne PH, Norris MD, Perini G, Fletcher JI, MacKenzie KL.

Cancer Res. 2016 Jun 15;76(12):3604-17. doi: 10.1158/0008-5472.CAN-15-0879. Epub 2016 Apr 13.

34.

ABC transporters as mediators of drug resistance and contributors to cancer cell biology.

Fletcher JI, Williams RT, Henderson MJ, Norris MD, Haber M.

Drug Resist Updat. 2016 May;26:1-9. doi: 10.1016/j.drup.2016.03.001. Epub 2016 Mar 17. Review.

PMID:
27180306
35.

In Search of Alternative Antibiotic Drugs: Quorum-Quenching Activity in Sponges and their Bacterial Isolates.

Saurav K, Bar-Shalom R, Haber M, Burgsdorf I, Oliviero G, Costantino V, Morgenstern D, Steindler L.

Front Microbiol. 2016 Apr 5;7:416. doi: 10.3389/fmicb.2016.00416. eCollection 2016.

36.

Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.

Evageliou NF, Haber M, Vu A, Laetsch TW, Murray J, Gamble LD, Cheng NC, Liu K, Reese M, Corrigan KA, Ziegler DS, Webber H, Hayes CS, Pawel B, Marshall GM, Zhao H, Gilmour SK, Norris MD, Hogarty MD.

Clin Cancer Res. 2016 Sep 1;22(17):4391-404. doi: 10.1158/1078-0432.CCR-15-2539. Epub 2016 Mar 24.

37.

Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis.

Carter DR, Sutton SK, Pajic M, Murray J, Sekyere EO, Fletcher J, Beckers A, De Preter K, Speleman F, George RE, Haber M, Norris MD, Cheung BB, Marshall GM.

Mol Oncol. 2016 Jun;10(6):866-78. doi: 10.1016/j.molonc.2016.02.004. Epub 2016 Mar 2.

38.

The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings.

Foppa IM, Ferdinands JM, Chaves SS, Haber MJ, Reynolds SB, Flannery B, Fry AM.

Int J Epidemiol. 2016 Dec 1;45(6):2052-2059. doi: 10.1093/ije/dyw022.

39.

High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients.

Kim PY, Tan O, Liu B, Trahair T, Liu T, Haber M, Norris MD, Marshall GM, Cheung BB.

Cancer Lett. 2016 May 1;374(2):315-23. doi: 10.1016/j.canlet.2016.02.021. Epub 2016 Feb 20.

PMID:
26902425
40.

Gaq signaling is required for the maintenance of MLL-AF9-induced acute myeloid leukemia.

Lynch JR, Yi H, Casolari DA, Voli F, Gonzales-Aloy E, Fung TK, Liu B, Brown A, Liu T, Haber M, Norris MD, Lewis ID, So CW, D'Andrea RJ, Wang JY.

Leukemia. 2016 Aug;30(8):1745-8. doi: 10.1038/leu.2016.24. Epub 2016 Feb 9. No abstract available.

PMID:
26859074
41.

Response to Hellenthal et al.

Ayub Q, Mezzavilla M, Pagani L, Haber M, Mohyuddin A, Khaliq S, Mehdi SQ, Tyler-Smith C.

Am J Hum Genet. 2016 Feb 4;98(2):398. doi: 10.1016/j.ajhg.2015.12.024. No abstract available.

42.

The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression.

Tee AE, Liu B, Song R, Li J, Pasquier E, Cheung BB, Jiang C, Marshall GM, Haber M, Norris MD, Fletcher JI, Dinger ME, Liu T.

Oncotarget. 2016 Feb 23;7(8):8663-75. doi: 10.18632/oncotarget.6675.

43.

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.

French JD, Johnatty SE, Lu Y, Beesley J, Gao B, Kalimutho M, Henderson MJ, Russell AJ, Kar S, Chen X, Hillman KM, Kaufmann S, Sivakumaran H, O'Reilly M, Wang C, Korbie DJ; Australian Ovarian Cancer Study Group; Australian Ovarian Cancer Study, Lambrechts D, Despierre E, Van Nieuwenhuysen E, Lambrechts S, Vergote I, Karlan B, Lester J, Orsulic S, Walsh C, Fasching PA, Beckmann MW, Ekici AB, Hein A, Matsuo K, Hosono S, Pisterer J, Hillemanns P, Nakanishi T, Yatabe Y, Goodman MT, Lurie G, Matsuno RK, Thompson PJ, Pejovic T, Bean Y, Heitz F, Harter P, du Bois A, Schwaab I, Hogdall E, Kjaer SK, Jensen A, Hogdall C, Lundvall L, Engelholm SA, Brown B, Flanagan JM, Metcalf MD, Siddiqui N, Sellers T, Fridley B, Cunningham J, Schildkraut JM, Iversen E, Weber RP, Brennan D, Berchuck A, Pharoah P, Harnett P, Norris MD, Haber M, Goode EL, Lee JS, Khanna KK, Meyer KB, Chenevix-Trench G, deFazio A, Edwards SL, MacGregor S; Ovarian Cancer Association Consortium.

Oncotarget. 2016 Feb 9;7(6):6353-68. doi: 10.18632/oncotarget.7047.

44.

Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.

Bassiri H, Benavides A, Haber M, Gilmour SK, Norris MD, Hogarty MD.

Transl Pediatr. 2015 Jul;4(3):226-38. doi: 10.3978/j.issn.2224-4336.2015.04.06. Review.

45.

Ancient DNA and the rewriting of human history: be sparing with Occam's razor.

Haber M, Mezzavilla M, Xue Y, Tyler-Smith C.

Genome Biol. 2016 Jan 11;17:1. doi: 10.1186/s13059-015-0866-z. Review.

46.

A New N-Acyl Homoserine Lactone Synthase in an Uncultured Symbiont of the Red Sea Sponge Theonella swinhoei.

Britstein M, Devescovi G, Handley KM, Malik A, Haber M, Saurav K, Teta R, Costantino V, Burgsdorf I, Gilbert JA, Sher N, Venturi V, Steindler L.

Appl Environ Microbiol. 2015 Dec 11;82(4):1274-1285. doi: 10.1128/AEM.03111-15. Print 2016 Feb 15.

47.

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma.

Decock A, Ongenaert M, Cannoodt R, Verniers K, De Wilde B, Laureys G, Van Roy N, Berbegall AP, Bienertova-Vasku J, Bown N, Clément N, Combaret V, Haber M, Hoyoux C, Murray J, Noguera R, Pierron G, Schleiermacher G, Schulte JH, Stallings RL, Tweddle DA; Children’s Cancer and Leukaemia Group (CCLG), De Preter K, Speleman F, Vandesompele J.

Oncotarget. 2016 Jan 12;7(2):1960-72. doi: 10.18632/oncotarget.6477.

48.

Association of coronary artery disease and chronic kidney disease in Lebanese population.

Milane A, Khazen G, Zeineddine N, Amro M, Masri L, Ghassibe-Sabbagh M, Youhanna S, Salloum AK, Haber M, Platt DE, Cazier JB, Othman R, Kabbani S, Sbeite H, Chami Y, Chammas E, El Bayeh H, Gauguier D, Abchee AB, Zalloua P, Barbari A.

Int J Clin Exp Med. 2015 Sep 15;8(9):15866-77. eCollection 2015.

49.

Caffeine Impact on Metabolic Syndrome Components Is Modulated by a CYP1A2 Variant.

Platt DE, Ghassibe-Sabbagh M, Salameh P, Salloum AK, Haber M, Mouzaya F, Gauguier D, Al-Sarraj Y, El-Shanti H, Zalloua PA, Abchee AB.

Ann Nutr Metab. 2016;68(1):1-11. doi: 10.1159/000441481. Epub 2015 Nov 21.

PMID:
26588584
50.

Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.

Carter DR, Murray J, Cheung BB, Gamble L, Koach J, Tsang J, Sutton S, Kalla H, Syed S, Gifford AJ, Issaeva N, Biktasova A, Atmadibrata B, Sun Y, Sokolowski N, Ling D, Kim PY, Webber H, Clark A, Ruhle M, Liu B, Oberthuer A, Fischer M, Byrne J, Saletta F, Thwe le M, Purmal A, Haderski G, Burkhart C, Speleman F, De Preter K, Beckers A, Ziegler DS, Liu T, Gurova KV, Gudkov AV, Norris MD, Haber M, Marshall GM.

Sci Transl Med. 2015 Nov 4;7(312):312ra176. doi: 10.1126/scitranslmed.aab1803.

PMID:
26537256

Supplemental Content

Support Center